Prediction: The Weight-Loss Drug Boom Could Be Just the Beginning for Lilly
Eli Lilly just crushed earnings and raised guidance, yet the most compelling part of its story has almost nothing to do with what already happened. The real question is whether the weight-loss boom is a peak or a launching pad for something far bigger.